Literature DB >> 371642

Prosthetic valve endocarditis resulting from Nocardia asteroides.

R H Falk, F R Dimock, J Sharkey.   

Abstract

Nocardia asteroides was isolated from the prosthetic valve of a 64-year-old woman who had died of endocarditis after aortic valve replacement. Multiple blood cultures had all been negative. This organism is increasingly being recognised as a pathogen and is usually sensitive to sulphonamides. These should be tried in culture negative endocarditis unresponsive to standard therapy.

Entities:  

Mesh:

Year:  1979        PMID: 371642      PMCID: PMC482022          DOI: 10.1136/hrt.41.1.125

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  4 in total

1.  Diagnostic and therapeutic considerations in Nocardia asteroides infection.

Authors:  D L Palmer; R L Harvey; J K Wheeler
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

2.  Prosthetic valve endocarditis. Analysis of 38 cases.

Authors:  W E Dismukes; A W Karchmer; M J Buckley; W G Austen; M N Swartz
Journal:  Circulation       Date:  1973-08       Impact factor: 29.690

3.  Prosthetic valvular endocarditis. A 12-year review.

Authors:  L Slaughter; J E Morris; A Starr
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

4.  Nocardial endocarditis following mitral valve replacement.

Authors:  N D Vlachakis; P C Gazes; P Hairston
Journal:  Chest       Date:  1973-02       Impact factor: 9.410

  4 in total
  3 in total

Review 1.  Endocarditis due to rare and fastidious bacteria.

Authors:  P Brouqui; D Raoult
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

2.  Nocardial endocarditis of an aortic valve prosthesis.

Authors:  G Ertl; K P Schaal; K Kochsiek
Journal:  Br Heart J       Date:  1987-04

3.  Implantable defibrillator pocket infection and bacteremia caused by Nocardia nova complex isolate.

Authors:  Keith Boell; Robert Gotoff; Michael Foltzer; Randle Storm; Paul P Bourbeau
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.